MedPath

The efficacy of Sonographic and biological pleurodesis Indicators of Malignant Pleural Effusion (SIMPLE) - a randomised trial

Completed
Conditions
10027656
10035597
malignant pleural effusion (MPE)
fluid around the lung caused by cancer
Registration Number
NL-OMON44184
Lead Sponsor
Oxford Respiratory Trials Unit, University of Oxford
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1. Clinically confident diagnosis of MPE requiring pleurodesis
2. written informed consent

Exclusion Criteria

1. Age <18 yrs
2. Poor prognosis (pleurodesis not offered in normal practice)
3. Irreversible contra-indication to drain insertion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Length of hospital stay (in days) during the initial hospitalisation. (from the<br /><br>time of randomisation until declared fit for discharge from hospital)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Pleurodesis success at 1 and 3 months post randomisation (radiological and<br /><br>clinical evaluation to assess success at 1 and 3 months (need for further<br /><br>pleural interventions))<br /><br><br /><br>2. Number of days in hospital post randomisation with drain in situ.(from<br /><br>randomisation till drain removal)<br /><br><br /><br>3. EQ-5D-5L questionnaire (at presentation, 1 and 3 months post randomisation)<br /><br><br /><br>4. VAS assessment (at baseline and post pleurodesis (Daily for 7 days and then<br /><br>weekly for 4 weeks))<br /><br><br /><br>5. Healthcare utilisation logs (at discharge, 1 and 3 months post randomisation)<br /><br><br /><br>6. Mortality (at 12 months post randomisation)<br /><br><br /><br>7. Pleurodesis failure at 1 and 3 months post randomisation (radiological and<br /><br>clinical evaluations to assess success at 1 and 3 months (need for further<br /><br>pleural interventions))</p><br>
© Copyright 2025. All Rights Reserved by MedPath